Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants
Clinical trial NCT05202145 · COMPLETED
Trial details
- NCT number
- NCT05202145
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2022-03-21
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.